Eagle’s Eye View: Can apixaban be used safely in patients with AF and end-stage kidney disease?
In this week’s View, Dr. Eagle explores the associations of apixaban dose with safety and effectiveness outcomes in patients with atrial fibrillation and severe chronic kidney disease. He then discusses a study that looks at stroke risk in women with atrial fibrillation. Finally, Dr. Eagle examines the DCM Precision Medicine Study of rare variant genetics and dilated cardiomyopathy severity.
Subscribe to Eagle’s Eye View
In this week’s View, Dr. Eagle explores stroke and bleeding risk in patients with atrial fibrillation and a CHA2DS2-VASC risk score of 1. He then discusses the important key points to remember in the recently released 2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial...
In this week’s View, Dr. Eagle explores a meta-analysis of direct oral anticoagulants for stroke prevention in patients with device-detected atrial fibrillation. He then discusses a 20-year study of sudden cardiac death in National Collegiate Athletic Association athletes. Finally, Dr. Eagle...